PMID- 28365864 OWN - NLM STAT- MEDLINE DCOM- 20180713 LR - 20181113 IS - 1720-8386 (Electronic) IS - 0391-4097 (Print) IS - 0391-4097 (Linking) VI - 40 IP - 9 DP - 2017 Sep TI - Long-term blood glucose monitoring with implanted telemetry device in conscious and stress-free cynomolgus monkeys. PG - 967-977 LID - 10.1007/s40618-017-0651-9 [doi] AB - AIMS: Continuous blood glucose monitoring, especially long-term and remote, in diabetic patients or research is very challenging. Nonhuman primate (NHP) is an excellent model for metabolic research, because NHPs can naturally develop Type 2 diabetes mellitus (T2DM) similarly to humans. This study was to investigate blood glucose changes in conscious, moving-free cynomolgus monkeys (Macaca fascicularis) during circadian, meal, stress and drug exposure. MATERIALS AND METHODS: Blood glucose, body temperature and physical activities were continuously and simultaneously recorded by implanted HD-XG telemetry device for up to 10 weeks. RESULTS AND DISCUSSION: Blood glucose circadian changes in normoglycemic monkeys significantly differed from that in diabetic animals. Postprandial glucose increase was more obvious after afternoon feeding. Moving a monkey from its housing cage to monkey chair increased blood glucose by 30% in both normoglycemic and diabetic monkeys. Such increase in blood glucose declined to the pre-procedure level in 30 min in normoglycemic animals and >2 h in diabetic monkeys. Oral gavage procedure alone caused hyperglycemia in both normoglycemic and diabetic monkeys. Intravenous injection with the stress hormones, angiotensin II (2 mug/kg) or norepinephrine (0.4 mug/kg), also increased blood glucose level by 30%. The glucose levels measured by the telemetry system correlated significantly well with glucometer readings during glucose tolerance tests (ivGTT or oGTT), insulin tolerance test (ITT), graded glucose infusion (GGI) and clamp. CONCLUSION: Our data demonstrate that the real-time telemetry method is reliable for monitoring blood glucose remotely and continuously in conscious, stress-free, and moving-free NHPs with the advantages highly valuable to diabetes research and drug discovery. FAU - Wang, B AU - Wang B AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Sun, G AU - Sun G AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Qiao, W AU - Qiao W AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Liu, Y AU - Liu Y AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Qiao, J AU - Qiao J AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Ye, W AU - Ye W AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Wang, H AU - Wang H AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Wang, X AU - Wang X AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Lindquist, R AU - Lindquist R AD - Data Sciences International, St. Paul, MN, USA. FAU - Wang, Y AU - Wang Y AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. FAU - Xiao, Y-F AU - Xiao YF AD - Crown Bioscience, Inc., Taicang, Jiangsu Province, The People's Republic of China. xiaoyongfu@crownbio.com. LA - eng PT - Journal Article DEP - 20170401 PL - Italy TA - J Endocrinol Invest JT - Journal of endocrinological investigation JID - 7806594 RN - 0 (Blood Glucose) SB - IM MH - Animals MH - Blood Glucose/*metabolism MH - Body Temperature/physiology MH - Consciousness/*physiology MH - Female MH - Glucose Tolerance Test/instrumentation/methods/trends MH - Locomotion/*physiology MH - Macaca fascicularis MH - Male MH - Telemetry/instrumentation/methods/*trends MH - Time Factors PMC - PMC5559582 OTO - NOTNLM OT - Continuous glucose monitoring OT - Diabetes OT - Glucose circadian OT - Implantable telemetry device OT - Nonhuman primate COIS- CONFLICT OF INTEREST: All of the authors are employee of Crown Bioscience Inc., except R Lindquist who is employee of Data Sciences International, St. Paul, MN, USA. The authors declare no conflict of interest in this study. ETHICAL APPROVAL: The study protocol and experimental procedures for using the animals were approved by the IACUC of Crown Bioscience Inc., which includes members from outside of the company. The approval number is AN-1308-016-19. INFORMED CONSENT: For this type of study formal consent is not required. EDAT- 2017/04/04 06:00 MHDA- 2018/07/14 06:00 PMCR- 2017/04/01 CRDT- 2017/04/03 06:00 PHST- 2016/11/11 00:00 [received] PHST- 2017/03/05 00:00 [accepted] PHST- 2017/04/04 06:00 [pubmed] PHST- 2018/07/14 06:00 [medline] PHST- 2017/04/03 06:00 [entrez] PHST- 2017/04/01 00:00 [pmc-release] AID - 10.1007/s40618-017-0651-9 [pii] AID - 651 [pii] AID - 10.1007/s40618-017-0651-9 [doi] PST - ppublish SO - J Endocrinol Invest. 2017 Sep;40(9):967-977. doi: 10.1007/s40618-017-0651-9. Epub 2017 Apr 1.